Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT03702725

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Loyola University Medical Center Maywood, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • The Ohio State University Wexner Medical Center/James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Completed

Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)

NCT05082116

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital-Hematology Fuzhou, Fujian, China
  • Nanfang Hospital, Southern Medical University-Haematology Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guizhou Medical University-Hematology Guiyang, Guizhou, China
View Trial Details
Completed

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

NCT01208766

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Canberra-CANBERRAHOSPITAL Canberra, Australia
  • AU-Melbourne-ALFRED Melbourne, Australia
  • AU-Sydney-CONCORD Sydney, Australia
View all 208 locations
View Trial Details
Completed

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

NCT03904134

Conditions
Acquired Aplastic Anemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +28 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, San Diego Medical Center La Jolla, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford Hospitals and Clinics Stanford, California, United States
View all 52 locations
View Trial Details

Related conditions